Gillett Drew A, Tigro Helene, Wang Yuan, Suo Zucai
Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306, USA.
Cells. 2024 Dec 18;13(24):2100. doi: 10.3390/cells13242100.
Fragile X Syndrome (FXS) presents with a constellation of phenotypes, including trouble regulating emotion and aggressive behaviors, disordered sleep, intellectual impairments, and atypical physical development. Genetic study of the X chromosome revealed that substantial repeat expansion of the 5' end of the gene fragile X messenger ribonucleoprotein 1 () promoted DNA methylation and, consequently, silenced expression of . Further analysis proved that shorter repeat expansions in also manifested in disease at later stages in life. Treatment and therapy options do exist, but they only manage symptoms. Up to now, no cure for disorders exists. In this review, we aim to provide an overview of biology and the latest research focused on developing therapeutic interventions that can potentially prevent and/or reverse FXS.
脆性X综合征(FXS)表现出一系列表型,包括情绪调节困难和攻击性行为、睡眠障碍、智力障碍以及非典型身体发育。对X染色体的基因研究表明,脆性X信使核糖核蛋白1(FMR1)基因5'端的大量重复扩增促进了DNA甲基化,从而使FMR1的表达沉默。进一步分析证明,FMR1中较短的重复扩增在生命后期也会表现出疾病症状。虽然确实存在治疗和疗法选择,但它们只能控制症状。到目前为止,还没有治愈脆性X综合征相关疾病的方法。在这篇综述中,我们旨在概述FMR1生物学以及专注于开发可能预防和/或逆转脆性X综合征的治疗干预措施的最新研究。